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ABSTRACT
This study examined the relationships among sociodemographic factors, social support, coping, and adherence to antiretroviral therapy (ART) among HIV-positive women with depression. The analyses reported here were limited to the 224 women receiving ART of 280 women
recruited from community-based HIV/AIDS organizations serving rural areas of three states
in the southeastern United States. Two indicators of medication adherence were measured;
self-report of missed medications and reasons for missed medications in the past month. Descriptive statistics, correlation, and regression analyses were performed to systematically identify sociodemographic, coping, and social support variables that predicted medication adherence. In regression analysis, three variables were determined to be significant predictors
accounting for approximately 30% of the variability in the self-report of reasons for missed
medications. Coping focused on managing HIV disease was negatively associated, while coping focused on avoidance/denial and number of children were positively associated with reasons for missed medications. Coping by spiritual activities and focusing on the present mediated the effect of social support on self-reported missed medications. The relationship of
predictor variables to self-report of missed medications was assessed using t test statistics
and logistic regression analysis to determine the odds of self-reported medication adherence.
Satisfaction with social support (p  0.04), and coping focused on managing HIV disease (p 
0.002) were the best positive predictors, whereas number of children (p  0.02) was the lone
significant negative predictor of medication adherence. The study findings have implications
for designing, implementing, and testing interventions based on social support and coping
theories for achieving better adherence to HIV medications.
INTRODUCTION

W

of antiretroviral medications, improvements in treatment op-

ITH THE ADVENT

tions, and introduction of highly active antiretroviral therapy (HAART), HIV disease has
undergone a transition from an acute terminal
illness to a chronic illness. Treatment with
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HAART has been shown to suppress viral
loads to undetectable levels in many patients.1
Continuous viral suppression, which is a primary goal of medical management of HIV infection, results in longer and healthier lives for
HIV-positive individuals.2 Viral replication
dramatically increases within days after withdrawing or missing antiretroviral doses.3 Failure to adhere to HAART not only results in
treatment failure but also in the development
of drug-resistant strains of HIV.4 It is estimated that in the United States, as many as
50% of persons with HIV disease who have
been treated with HAART now have strains
of HIV that are resistant to at least one of the
available antiretroviral drugs.5 Persons who
do not maintain a 95% adherence rate to
HAART are at risk for treatment failure and
adverse clinical outcomes.4 Once established,
resistance may become irreversible through
a process of evolution and diversification.5
Therefore, strict adherence to the prescribed
drug regimen is a critical factor in controlling
progression of the disease, thereby reducing
morbidity and mortality in individuals with
HIV disease.
Achieving a nearly perfect adherence to a
complex regimen of medications is a remarkably difficult and challenging task.2,6,7 Despite
the efforts of health care professionals to encourage adherence, many individuals with
HIV disease continue to miss doses, take lower
doses than prescribed or fail to take their medications as directed.8
Numerous studies have focused on identifying factors influencing medication adherence.
Many of these studies have focused on barriers to adherence such as depression and substance abuse. Both social support and coping
are known factors influencing the outcomes of
chronic illness, and many studies have focused
on the roles social support and coping may
play in medication adherence within the context of HIV disease.9 However, very little is
known about the population of rural women
living with HIV disease, including factors that
may influence their adherence to ART medication regimens. Given the geographical and social barriers to needed support and services
faced by individuals with HIV disease living in
rural areas, an examination of factors influenc-
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ing the medication adherence of rural women
is warranted.
This study examined the relationships
among perceived social support, coping strategies and antiretroviral medication adherence in
a sample of 224 rural women with HIV disease,
a subset of participants enrolled in a longitudinal clinical trial designed to test the efficacy
of a peer-based social support intervention. The
cross-sectional data used in the analyses were
obtained during baseline interviews with study
participants. Based on theory of psychological
stress, coping, and adaptation, analyses were
conducted to examine the predictive value of
both social support and coping for adherence,
and also to examine the role of coping as a mediator of the relationship between social support and medication adherence.

BACKGROUND
The theoretical perspective guiding this analysis is Lazarus and colleagues’ cognitive–phenomenological model of psychological stress and
coping, which identifies the antecedents and processes that account for individual differences in
adaptational outcomes of stressful life situations
such as chronic illness.10–12 Important to the present study are the roles of social support and coping in accounting for individual differences in
medication adherence within the context of HIV
disease among rural women.
Social support is conceptualized as one of a
number of antecedent stress resistance resources that contribute to positive adaptational
outcomes.10–12 Having people in one’s life during a stressful episode from whom one receives
emotional, informational, and/or tangible support is a major factor mediating such outcomes.
It is postulated that individuals who have access to resources such as social support are
more likely to be effective in managing stressful situations and less likely to experience poor
outcomes. Conversely, those who are deficient
in resources such as social support are less able
to manage the situation effectively, and thus
are more likely to experience negative outcomes.12 Extensive evidence suggests that social support contributes to positive adaptational outcomes, even in the most difficult of
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situations, and its absence contributes to poor
outcomes. For example, social support has been
found to mitigate depressive symptoms of
HIV-positive individuals.13
Social support is a complex construct that is
difficult to define and measure. The general
consensus is that social support is a multidimensional construct that includes the sources
of support, i.e., who in the social network provides support, the types of support (e.g., emotional, informational, or tangible), and one’s
satisfaction with the support received.14 There
is less agreement concerning what constitutes
social support, how it works, and what types
of support are most effective in a particular
context. Although the emphasis of research has
been on the positive dimensions of social support, it is acknowledged that some attempts at
support are actually perceived by the recipient
to be unhelpful or negative and undesirable.15
The desirability and potential effectiveness of
different types of support depend to a great extent on the context of the situation and the type
of support needed, and support may be perceived negatively when the support provided
does not match the needs of the situation.12
In stress theory, coping is conceptualized as
a process that mediates the relationship between the antecedents and outcomes of psychological stress. Coping responses include all
cognitive and behavioral strategies used by individuals to manage a stressful situation. There
are two major functions of coping: (1) management of emotional distress and (2) management of those problems causing psychological stress.12 A number of coping strategies,
primarily cognitive in nature, focus on managing one’s emotional distress; such strategies are
called emotion-focused coping strategies. In
contrast, coping strategies that focus on managing the situation causing distress are called
problem-focused coping strategies. It is postulated that the effectiveness of any one coping
strategy is dependent upon the match between
the strategy and what is needed in the situation.12 In situations of chronic illness, there is
extensive evidence that problem-focused coping strategies are more effective in producing
positive adaptational outcomes over the longterm than emotion-focused strategies.13,16,17
Similar findings have been reported in studies
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of coping with HIV disease.18 Similar to social
support, coping strategies must match the demands of the situation to be effective.12
Medication adherence is an important adaptational outcome for HIV disease. As noted previously, HIV patients must show a high level of
adherence to HAART to suppress viral loads
and avoid development of resistant strains of the
virus. It is estimated that adherence rates greater
than 95% are necessary to achieve maximum
HIV suppression.19 Failure to adhere to a medication regimen results in virologic failure,
which is defined as an increase in the rates of
viral replication and mutation following initiation of the regimen.20 It is estimated that average rates of nonadherence to antiretroviral therapy range from 50% to 70%.21 Understanding of
those factors contributing to adherence as well
as nonadherence is essential to the development
of interventions that are predictably effective in
promoting adherence. Recent efforts to test
interventions tailored to address such factors
have demonstrated effectiveness in increasing
adherence. Deschamps and colleagues22 reported nonadherence rate of 40% in a population of HIV patients using medication event
monitoring system. Findings from another
study suggested that appropriately trained
HIV/AIDS case managers can play a pivotal
role in improving HAART adherence among
their clients.23 Recent multidisciplinary programs have successfully increased HAART adherence among intervention participants as
compared to those in the control group.24
Many studies in the past have examined the
association between availability of social support and HIV medication adherence. Cox9 found
emotional support to be a significant predictor
of medication drug adherence among persons
with HIV disease. Other studies found perceived social support to be a significant predictor of compliance.25,26 Some studies have examined how coping strategies influence medication
adherence in individuals with HIV disease. In
one such study, Heckman and colleagues27
found active coping strategies to be positively
associated with medication adherence.
A model of medication adherence within the
context of HIV disease is shown in Figure 1.
The model demonstrates the link between antecedent factors, including sociodemographic
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Mediating Variables
Coping
Denial/Avoidance
Spiritual Activities
Managing HIV Disease
Positive Thinking
Focus on Present
Focus on Others
Seeking Social Support
Seeking Information

Social Support
HIV Drug Adherence

Availability of Social
Support

Reasons for Missing
Medications

Satisfaction with
Social Support

Missed Medications

Socio-demographic
Characteristics

Antecedent Variables
FIG. 1.

Outcome Variable

Model of social support, coping and HIV medication adherence.

variables and social support variables, and the
outcome of HIV medication adherence. Additionally, coping strategies are included as process variables that mediate the relationship
between social support and medication adherence and account for individual differences.
The analysis reported here was an attempt to
increase understanding of the relationships
among social support, coping, and medication
adherence among individuals with HIV disease as a means of identifying potential points
of intervention that will support HIV medication adherence.
METHODS
The cross-sectional data reported here were
collected in the first of three interviews of a

longitudinal study designed to test the efficacy
of a peer-based social support intervention designed for rural women with HIV disease and
depression.
Sample
The original sample included 280 HIV-infected women recruited from 10 communitybased HIV/AIDS service organizations serving
rural areas of 3 states in the southeastern
United States. The analysis was limited to the
subset of 224 participants who were currently
receiving antiretroviral therapy. Each recruitment site provided a range of standard
HIV/AIDS specific services, including HIV
testing and counseling, early intervention, case
management, and treatment. Criteria for inclusion in the study were: (1) residence in a rural
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area or town with a population less than 50,000;
(2) age 18 or older; (3) verified HIV-positive status; (4) English-speaking; (5) no evidence of dementia verified by medical records; (6) no prior
peer counseling experience; and (7) a score of
16 or higher on the Center for Epidemiological
Studies-Depression (CES-D) scale. The cutoff
point of 16 was selected, as scores at this level
or higher are significantly correlated with a
clinical diagnosis of depression.28 Only 20 (7%)
of the 300 rural women screened for depressive
symptoms did not meet the inclusion criteria.
Demographic characteristics of the sample
are summarized in Table 1. The sample was
largely single (83%), African American women
(82%) living alone with their children. Fortythree percent of the sample reported annual
household incomes less than $5,000, and 78%
less than $10,000. Just over half of the sample
lived in small towns and nearly half lived on
rural routes. The age of participants ranged
from 18 to 66 years, with a mean age of 39.75
years (standard deviation [SD]  10.37 years).
Forty-one percent of the participants had not
earned a high school degree. Only a small portion of the sample (21%) was employed either
full or part time. Some of these women had a
TABLE 1.
Variable
Race
Age (years)

Education
Annual household income
Employed full/part time
Marital status
Living situation
Live in town?

clinical diagnosis of depression and were on
antidepressant medications and/or counseling. However, depression was not a focus of
this particular analysis. Patterns of risk for depression among this sample and its influence
on medication adherence are described elsewhere.29,30
Procedures
The staff of cooperating agencies served as
intermediaries for the investigators in recruitment by distributing information about the
study to potential participants. Women who
were interested in participating in the study
and gave their consent were contacted by female research assistants hired from the local
area who received intensive training in recruitment and interviewing techniques. An initial meeting was scheduled to explain the study
procedures and to complete the process of informed consent and screening to determine
whether or not they met the study inclusion criteria. Those who met the criteria were scheduled for an initial interview conducted at the
participant’s home or other mutually agreedupon site where privacy and confidentiality

SAMPLE DEMOGRAPHICS (n  224)
Levels

Frequency

African American (0)
Other (1)
18–30 (0)
31–45 (1)
 45 (2)
Missing
Less than HS degree (0)
HS degree (1)
College/technical training (2)
$5,000 (0)
 $5,000–$9,999 (1)
$10,000 and higher (2)
No (0)
Yes (1)
Singlea (0)
Non-singleb (1)
Live alone (0)
Live with others (1)
No (0)
Yes (1)
Missing

183
41
43
115
65
1
92
72
60
97
77
50
176
48
186
38
40
184
114
109
1

Numbers in parentheses following categorical variables designate coding level for multivariate levels.
aThis category includes those never married, separated, divorced or widowed.
bThis category includes those married or living with a partner.

%
81.7
18.3
19.2
51.3
29.0
41.1
32.1
26.8
43.3
34.4
22.3
78.6
21.4
83
17
18
82
51
49
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could be maintained. Research assistants read
all interview items to the participants and
recorded their responses. Interviews lasted
from one to two hours, and participants were
paid $30.
Instruments
The properties of study instruments are summarized in Table 2.
Social support. Social support was measured using two scales that together measure
the three major dimensions of social support
identified in the literature: the functional components of social support (availability of different types of support), the source of support
(network), and the quality of available support
(e.g., satisfaction). The functional component of
social support was measured by the Medical
Outcomes Study Social Support Survey (MOSSSS).31 Developed for use with chronically ill
patients, the scale is designed to measure the
individual’s perception of the availability of
support along four dimensions: emotional/informational, affectionate, tangible, and positive
social interaction. The 19 items describe the different types of support, rated on a 5-point response format of how often a type of support
is available if needed, with responses ranging
from none of the time (1) to all of the time (5).
TABLE 2.

PROPERTIES

Higher scores reflect higher levels of perceived
availability.
The short form of the Social Support Questionnaire (SSQ6)32 was used to measure both
the source of support and satisfaction with social support. The SSQ6 contains six items derived from the original 27-item SSQ.33 Social
support was measured in two parts. The number of available support persons was measured
by asking the respondent to list up to nine people on whom they can rely for the set of circumstances described in each item. The degree
of satisfaction with available support was then
measured for each item using a 6-point response format ranging from very satisfied (6)
to very dissatisfied (1). For the present analysis we focused on availability and quality (satisfaction) of social support.
Coping. Coping responses were measured
by the Family Coping Project Coping Scale
(FCPCS).34,35 The scale was developed using
516 descriptions of coping collected from 267
HIV-infected women from rural and urban areas enrolled in a longitudinal study of women’s
responses to HIV/AIDS. Using qualitative
analysis, major categories of coping were identified and items representing each category
were developed; a 54-item scale resulted. Exploratory factor analysis using data collected
with the instrument in subsequent interviews
OF

STUDY INSTRUMENTS
Statistics for sample

Measure
Social support
Family Coping Project Coping Scale

Reasons for missed medications

Subscales

# Items

Range

Mean

SD



Availability of support
Sources of support
Satisfaction with support
Total coping
Living positively
Managing the illness
Seeking support family
Isolation/withdrawal
Spiritual activities
Seeking information
Denial/avoidance
Seeking peer support
—

6
6
54
9
8
7
7
5
2
6
9
14

0–6
5–36
49–142
1–27
6–24
0–21
0–21
1–15
0–6
0–18
0–23
0–42

5.12
29.04
100.16
20.96
19.18
12.14
11.64
11.74
4.47
9.32
10.73
9.31

1.74
10.01
17.40
4.74
4.14
5.01
4.43
2.90
1.56
3.90
4.89
10.42

0.97
0.97
0.87
0.80
0.78
0.82
0.69
0.76
0.65
0.66
0.67
0.95

Note: The second proxy variable for the medicine adherence was missed HIV-medication, which was dichotomized
into two categories of never missed medications (0) indicating complete adherence and missed medication at least
once in previous month (1) indicating nonadherence.
SD, standard deviation.
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with the women generated five valid and reliable subscales: avoidance/denial, managing
the illness, spiritual activities, seeking social
support, and focusing on others. The construct
validity of the instrument for the current sample of rural women with HIV was assessed using principal components factor analysis. Eight
valid and reliable coping factors were identified for the study sample (Table 2). Each item
was rated on a 4-point response format of the
frequency each strategy had been used in the
past 3 months, with responses ranging from
never (1) to always (4). The items comprising
each factor were summed for a total subscale
score.
The coping responses represented by the factors are similar to those identified in other measures of coping. However, a coping response
unique to women with HIV disease was managing the illness. The items making up this factor represent efforts to promote and maintain
health and include such behaviors as practicing healthy habits like eating right, exercising,
and getting enough rest, avoiding drugs and
alcohol, and keeping health care appointments.
Medication adherence. Medication adherence
was measured by two proxy variables: self reported missed HIV-medications and reasons
for missed medications in the past month. For
the purpose of this study, responses to items
about missed HIV-medications were used to
categorize study participants into two categories of complete adherence (never missed
medications) or nonadherence (missed medications at least once in previous month). This
approach was used because previous research
has indicated that nearly 100% adherence to
HAART is necessary to obtain the best results.
The second proxy variable, the frequency of
self-reported reasons for missed medications in
the past month, was assessed by a modified
version of the Adult AIDS Clinical Trials Group
Adherence Baseline Questionnaire.36,37 Reasons for missed medications was a continuous
score based on 14 commonly reported reasons
for missed medications rated on a 4-point scale
ranging from 0 (never) to 3 (often). When these
14 items were summed for a total score; higher
scores indicated a greater degree of endorsement of reasons for missed medications. Factor

analysis of the reasons for missed medications
yielded only one factor suggesting that all the
responses measured the same construct. Internal consistency reliability of the scale for the
sample was high (  0.95).

ANALYSES
Frequencies and percentages were calculated
to determine the distribution of the sample on
sociodemographic variables. 2 test was performed to determine which sociodemographic
variables were significantly associated with
medication adherence variables. Pearson’s correlations and analysis of variance were used to
determine which social support, and coping
variables were related to adherence variables
and should be included in subsequent analyses. The dependent variable was regressed on
the variables found significant in the preliminary analysis to identify the significant predictors of adherence.
The mediating effect of coping was analyzed
in three steps using those social support, coping, and medication adherence variables that
were found to be significantly associated. First,
simple regression analysis was performed for
reasons for missed medications on social support variables. Next, simple regression analysis was performed for each of the coping variables that were found to be significantly
associated with social support variables, using
social support as an independent variable. In
the third step, the focus was on the outcome of
self-reported reasons for missed medications in
the past month. Three sets of multiple regression analyses were performed for missed medications on each of the social support and coping variables that were found significant in the
earlier steps.
For the other proxy variable, t tests were
used to identify the differences in the means of
predictor variables for the two adherence levels: never missed medications and missed medications at least once in the previous month.
Significant social support and coping variables
were then entered into logistic regression analysis to estimate the odds that they were significant predictors of the two levels of missed
medications: (1) participants with scores of 0
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indicating no missed medications in the past
month and (2) participants with scores greater
than 0 indicating some degree of missed medications in the past month. The significance
level for all analyses was set at p  0.05.
In addition, Pearson’s correlations were performed to explore the patterns of relationships
that might be present among the various reasons for missed medications and the social support variables.

FINDINGS
Of the 280 women in the study sample, 224
were receiving combination antiretroviral therapy at the time of interview and thus were included in the analyses. Of these, 81 (36.16%) reported never skipping medications, while 133
(59.38%) were nonadherent to their medication
regimen to various extents in the past month;
10 refused to provide relevant data. Approximately 25% of the participants reported missing doses of their medications within the past
2 weeks. Of all the sociodemographic, social
support and coping variables considered individually, 8 were significantly correlated with
the measure of reasons for missed medications
(Table 3). Two variables, coping by denial/
avoidance (p  0.0002), and number of children
given birth to (p  0.005), were positively correlated with reasons for missed medications,
while availability of social support (p  0.01)
and coping by spiritual activities (p  0.005),
managing HIV disease (p  0.0001), positive

thinking (p  0.0001), focusing on others (p 
0.02), and focusing on the present (p  0.0003),
were negatively correlated with reasons for
missed medications. Next, in multiple regression analysis, the measure of reasons for
missed medications was regressed on the significant covariates (Table 4). The regression
model was significant (F  11.55; p  0.0001)
and accounted for 30% of the variability in reasons for missed medications. Three of the 8
variables entered in the regression model were
significant predictors. Coping by denial/avoidance (p  0.0001), and number of children
given birth to (p  0.0003) were positive predictors of reasons for missed medications,
whereas coping by managing HIV disease (p 
0.0001) was a negative predictor. When nonsignificant variables were eliminated from the
model using backward stepwise regression
analyses; there were only minor changes in the
adjusted R2 value.
Two out of the three coping variables examined, focusing on the present and spiritual activities, were found to mediate the effect of social support on reasons for missed medication
(Table 5). In the first step of the analysis, the
score for reasons for missed medications was
regressed on available social support and the
model was significant (p  0.0161). In the next
step, each of the three coping variables (focusing on others, focusing on present and spiritual
activities) was individually regressed on available social support, and each of the models was
significant (p  0.002, p  0.0032, and p 
0.0029, respectively). In the final step, three sep-

TABLE 3. PEARSON’S CORRELATIONS BETWEEN PREDICTOR
VARIABLES AND REASONS FOR MISSED MEDICATIONS
Predictor variables
Availability of social support
Satisfaction with available support
Coping: denial/avoidance
Coping: seeking social support
Coping: spiritual activities
Coping: managing HIV disease
Coping: focusing on others
Coping: positive thinking
Coping: focus on present
Coping: information seeking
Number of children given birth to
ap

 0.05.

Reasons for missed medications
0.16a
0.08
0.25a
0.05
0.19a
0.40a
0.16a
0.31a
0.24a
0.12
0.19a
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TABLE 4.

MULTIPLE REGRESSION ANALYSIS

OF

REASONS

FOR

Variable statistics

PREDICTOR VARIABLES

ON

Model statistics


Standard error

p

F

p

R2

Adjusted R2

0.4375
0.3869
0.0127
0.0445
0.8007
0.5421
0.9808
1.1933

0.3628
0.0955
0.1908
0.3096
0.1734
0.4350
0.5989
0.3257

0.2291
 0.0001a
0.9470
0.8860
 0.0001a
0.2141
0.1030
0.0003a

11.55

 0.0001

0.3036

0.2773

Variable
Availability of social support
Coping: denial/avoidance
Coping: spiritual activities
Coping: focusing on others
Coping: managing HIV disease
Coping: positive thinking
Coping: focus on present
Number of children given birth to
ap

MISSED MEDICATIONS

 0.05.

arate regression analyses were performed with
reasons for missed medication regressed on
available social support in combination with
each of the three coping variables. The results
indicated that coping by the use of spiritual activities and focusing on the present each mediated the effect of social support on the outcome
variable (p  0.02, and p  0.001, respectively).
Social support, which was a significant predicTABLE 5.

COPING

AS

MEDIATOR

BETWEEN

tor of adherence in the first step, became nonsignificant in the third step when coping variables were added to the models, with the coping variables (use of spiritual activities and
focusing on the present) being the significant
predictors of adherence.
Scores on the second measure of medication
adherence, self-reported missed medications in
the past month, were used to group partici-

AVAILABLE SOCIAL SUPPORT

AND

REASONS

FOR

MISSED MEDICATIONS

Step 1: Simple Regression Analysis of Reasons for Missed Medications on Available Social Support
Variable statistics
Variable
Available Social Support



Standard error

p

0.9840

0.4056

0.0161

Step 2: Simple Regression Analysis of Selected Coping Variables on Available Social Support
Variable statistics for
available social support
Dependent variable
Coping: Focusing on others
Coping: Focus on Present
Coping: Spiritual Activities


0.2967
0.1423
0.4322

Standard error

p

0.0948
0.0471
0.1452

0.0020
0.0029
0.0032

Step 3: Multiple Regression Analysis of Reasons for Missed Medications on Predictor Variables
Variable statistics
Independent variables
III
III
III
III
III
III

Available Social Support
Coping: Focusing on others
Available Social Support
Coping: Focus on Present
Available Social Support
Coping: Spiritual Activities

aStatistically

Model statistics



Standard error

p

F

0.8263
0.5359
0.7217
1.8459
0.7904
0.4449

0.4119
0.2855
0.4051
0.5659
0.4094
0.1854

0.0461
0.0618
0.0765
0.0013a
0.0548
0.0172a

4.74

0.0097

0.0415

0.0327

8.39

0.0003

0.0712

0.0627

5.89

significant results for medication effect (for all analyses p  0.05).

R2

p

0.0032

0.0510

Adjusted R2

0.0423
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pants into two adherence categories; those participants who reported no missed medications
(adherent) coded as “0” and those participants
who missed one or more doses of medications
during the past month (non-adherent) coded as
“1.” t tests were conducted to identify the significant differences in means of sociodemographic, social support, and coping variables
for the two groups (Table 6). Of the 12 variables
assessed, significant differences in means were
found for number of children (p  0.05), satisfaction with available support (p  0.02), coping by managing illness (p  0.0003), and coping by positive thinking (p  0.049). Coping by
information seeking approached significance
(p  0.07). Significant variables were entered
into logistic regression analysis to determine
the odds they were significant predictors of adherence/nonadherence categories (Table 7).
Satisfaction with available social support (p 
0.04), and coping by managing HIV disease
(p  0.002) were found to be the best positive
predictors of drug adherence, whereas number
of children (p  0.02) was found to be a negative predictor of medication adherence.
An additional analysis was conducted to examine the pattern of relationships between social support and the reasons for missed medication items. Seven of the 14 reasons for
missed medications were significantly negatively correlated with availability of social support (Table 8): (1) had too many pills; (2)

wanted to avoid side effects; (3) did not want
others to notice; (4) fell asleep; (5) felt sick; (6)
felt depressed; and (7) problem taking pills at
specified times.

DISCUSSION
Findings of the study demonstrated that of
the 224 women in the sample receiving combination antiretroviral therapy, 133 (59.38%)
were nonadherent to their drug regimens at
least once during the past month. This finding
is consistent with the reported rates of nonadherence to antiretroviral therapy in previous
research.21 However; it is relatively high compared to the rates reported by recent studies.22–24 The finding supports that medication
adherence is an important issue for rural
women with HIV disease.
In this study we examined the role of social support and coping strategies in adherence to the complex multidrug regimens for
HIV infection. Previous research has clearly
demonstrated the importance of maintaining
a nearly perfect adherence to anti-retroviral
drug regimens in order to decrease morbidity and mortality, to improve the quality of
life of HIV-infected individuals, and to prevent development of drug resistant strains of
the virus.2,4 Social support and coping are particularly important because they can be modi-

TABLE 6. t-TEST STATISTICS OF SELECTED ANTECEDENT VARIABLES
MISSED MEDICATION GROUP (ADHERENT VS. NONADHERENT)
Never missed medication

BY

Missed medication

Variable

n

Mean

SD

n

Mean

SD

p Value

Availability of social support
Satisfaction with available supporta
Coping: avoidance
Coping: seeking social support
Coping: spiritual activities
Coping: managing illnessa
Coping: focusing on others
Coping: positive thinkinga
Coping: focus on present
Coping: information seeking
Number of childrena

81
80
81
81
81
81
81
80
81
81
81

5.284
30.963
18.235
21.704
16.198
22.543
9.432
7.325
4.914
11.506
2.173

1.60
8.94
6.11
7.72
3.99
3.36
2.55
1.74
1.24
2.80
1.53

133
132
133
133
133
133
133
133
133
133
133

5.008
27.758
19.383
20.835
15.406
20.579
9.226
6.805
4.940
10.714
2.65

1.79
10.54
6.59
7.38
3.66
4.47
2.46
1.94
1.21
3.55
2.04

0.24
0.02
0.20
0.42
0.15
0.0003
0.56
0.04
0.88
0.07
0.05

 0.05.
Note: the observations (n) do not add to 224 due to missing data.
SD, standard deviation.
ap
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TABLE 7. SUMMARY OF LOGISTIC REGRESSION ANALYSIS PREDICTING
MISSED MEDICATION GROUP (ADHERENT VS. NONADHERENT)
Variable
Satisfaction with available supporta
Coping: Managing HIV diseaseb
Coping: Positive thinking
Coping: Information seeking
Number of Childrena



Standard error

Odds ratio

95% Confidence interval

0.0326
0.1493
0.0039
0.0016
0.1933

0.0163
0.0490
0.0993
0.0531
0.0844

1.033
1.161
0.996
1.002
0.824

1.001–1.067
1.055–1.278
0.820–1.210
0.903–1.112
0.699–0.973

 0.05.
 0.01.
Note: 13 observations were deleted due to missing values for the response or explanatory variables.
ap
ap

fied through a variety of intervention approaches, including cognitive, behavioral, and
social approaches.
The finding that coping by denial/avoidance
was a predictor of non-adherence to medications was not unexpected. Denial has long been
associated with poor outcomes in chronic illnesses. Similarly, the finding that coping by
managing HIV disease was a negative predictor of nonadherence was expected as this coping strategy represents an active approach to
taking control of the disease through health
promoting behaviors. This was consistent with
the findings of other researchers who reported
that individuals who engaged in more active
coping in response to HIV-related life stressors
were more likely to adhere to their medication
regimens.27 It was interesting to note that the
number of children given birth to had an influence on medication adherence, such that the
number of reported missed medications inTABLE 8.

creased as the number of children increased. A
well-established fact in women’s health is that
women very often put the needs of their children above their own,38 and this is a possible
explanation for the association between number of children and adherence.
We also found that coping by the use of spiritual activities and focusing on the present both
mediated the effect of social support on medication adherence. There are several possible
explanations for this finding. First, the sample
was recruited from the southern United States,
an area known to be dominated by conservative values and norms that include religion.
Furthermore, the large majority of the sample
was African American, and religion is a core
component of the southern African American
culture. Additionally, the church is a valued
source of support in the southern African
American culture. Ethnographic studies have
found that African American women’s spiri-

PEARSON’S CORRELATIONS BETWEEN EACH OF THE REASONS
MISSED MEDICATIONS AND AVAILABLE SUPPORT

FOR

Reasons for missed medications
Away from home
Busy with other things
Simply forgot
Had too many pills
Wanted to avoid side effects
Did not want others to notice
Had a change in daily routine
Felt drug was toxic
Fell asleep
Felt sick/ill
Felt depressed
Problem taking pills at specified times
Ran out of pills
Felt good
aSignificant

correlations.

Correlation coefficient

p value

0.01
0.09
0.10
0.17
0.13
0.15
0.11
0.08
0.14
0.20
0.19
0.16
0.08
0.07

0.83
0.16
0.11
0.01a
0.04a
0.03a
0.10
0.22
0.03a
0.00a
0.00a
0.02a
0.26
0.31
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tual beliefs are often linked closely to beliefs
about health, disease, and behavior.39 One
study in particular examined the association of
religion, religious beliefs and practices with
treatment adherence among individuals with
HIV disease in one of the southern states.40 The
results of this study indicated that certain religious practices and beliefs were among the
multiple factors influencing adherence. The
role of focusing on the present in this equation
is less clear. Focusing on the present is an important coping strategy for effective stress
management. By focusing on the present, one
is less likely to focus on the future threats posed
by the illness, and hence, less distress is generated.12 Because individuals with chronic illness frequently learn how to cope with the illness through their interaction with others with
the disease, the support received from others
with HIV disease could be a factor accounting
for the use of this coping strategy by the
women in this study.
Coping by managing HIV disease was found
to be an important predictor of medication adherence. The finding suggests that a belief in
one’s ability to control the disease may be the
key to adherence. This is consistent with the
theory of psychological stress and coping,
where emphasis is placed on the importance of
belief in one’s ability to affect outcomes by effectively coping with difficult life situations
such as chronic illness.12 Satisfaction with social support was also found to be a significant
predictor of medication adherence, a finding
that is consistent with current thought on the
importance of the match between the type of
support that is available and what is desired or
needed to effectively cope with a specific situation.12 Satisfaction with available support is a
good indicator of the quality of this match.
However, the findings do not provide insight
into the specific types of support that may promote medication adherence within the context
of HIV disease. Further research is needed to
identify the types of support that are not only
the most satisfying within the context of HIV
disease, but which also support positive outcomes such as adherence to medications. Such
findings are central to the development of predictably effective social support interventions
for medication adherence. Despite such limita-
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tions, the findings support the need to assess
the individual’s perception of the support they
want and/or need in order to achieve adherence to their medication regimen.
The study is limited in several ways. Medication adherence was assessed by self-report
and true adherence levels are often overestimated when self-reported.41 The reduction of
data for missed medications into adherent and
nonadherent categories reduces variability in
the dependent variable and this may have been
a factor in findings of nonsignificance of some
independent variables. The scope of the analysis was limited to an examination of social support and coping as predictors of medication adherence, and there may be other important
predictors not represented in this analysis. The
relationship among medication adherence and
two such predictors, sleep disturbance and depression, are reported elsewhere.30 Future research is warranted to identify such factors and
understand their relation to medication adherence. Another limitation is the exclusion of
HIV-positive women with CESD scores of less
than 16, and it is possible that the dynamics of
medication adherence may differ for women
who are not depressed. Additionally, the sample was limited to rural women from one geographic region of the United States and the results cannot be generalized to women from
urban areas or other geographic regions.
It is well established that adherence to HIV
medication is a key factor in managing the progression of the disease. The findings of the
study have implications in designing, implementing, and testing interventions based on social support and coping theories. Social support
and coping are particularly important because
they can be modified through a variety of intervention approaches, including cognitive, behavioral, and social approaches.

CONCLUSION
Findings indicate that social support and
coping strategies influence adherence to antiretroviral drug regimens among rural women
with HIV disease. It is not mere availability of
social support, but the satisfaction of the available support which is important for better ad-

SOCIAL SUPPORT, COPING, AND MEDICATION ADHERENCE

herence. Coping by spiritual activities and focusing on the present mediated the effect of social support on medication adherence. Satisfaction with available support and coping by
managing HIV disease were the best positive
predictors of medication adherence, whereas
the number of children was a negative predictor of medication adherence. Further research
is warranted to identify and better understand
the complex factors influencing drug adherence among different populations and in different geographic regions.
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